Splashx_health_1_728x90

Fireside Chats

16340

Doerr: “Ideas are easy. Execution is everything.”

If you look at the "basic math," unicorns may be pointing us to a new bubble

Innovation series by Ronny Kerr
December 2, 2015
Short URL: http://vator.tv/n/41cb

Think you have an amazing, incredible, billion-dollar idea for a startup that will completely transform the world and the way we live? Well John Doerr, a self-professed technology junkie who “worships at the altar of ideas and innovation,” has some news for you:

“Ideas are easy. Execution is everything.”



The pithy remark came at the end of an onstage conversation between the legendary Kleiner Perkins Caufield & Byers (KPCB) venture capitalist and Paul Martino (General Partner at Bullpen Capital) at the second annual Post Seed (#postseedconf) event in San Francisco yesterday.

It’s simple but forceful, and in a few words explains why ideas as simple as “online retail” or “on-demand taxis” end up being the basis of massive technology companies (like Amazon or Uber).

In almost an hour of conversation that swung from what makes a worthy Series A investment to innovation in the healthcare industry, we were bound to turn our attention to unicorns and the prospects of another tech crash.

First, Doerr explained the “basic math” of the unicorn problem. Google, he said, has acquired one company a week for the last five years, but there have only been five instances where the company paid more than $1 billion for an acquisition.

Today, there are almost 150 companies considered unicorns, or private companies valued at or above $1 billion. Acknowledging the fact that most companies don’t exit through IPO but rather through acquisition, how is the math going to work out?

When you add to this that nearly 100 of the unicorns are based in the United States (“Americorns,” as we should never ever call them again), then “you expect there’s going to be a great coming disaster” like the dot-com bubble in the 90s.

“But,” he added, “the scale is different,” arguing that the industry today is spending less than it was during the last boom.

Still, the basic math is going to lead somewhere, and massive private valuations aren’t necessarily a good thing for these companies. “Having a $1 billion valuation can be a real problem,” said Doerr. “Being a unicorn is really an albatross.”

In the end, the experienced venture capitalist shared some tangible wisdom with entrepreneurs in the audience. The entrepreneur should set the valuation and the investor will set the terms. But don’t just invent pie-in-the-sky valuations.

“Go for clean terms and let the market set the valuation,” Doerr said. “Don’t choose your investor based on valuation, choose it based on the value you think you’re going to get by hiring that investor.”

Investors are hard to fire. That's why entrepreneurs need to find an investor that will truly be a partner. They're not going to be running the company or setting strategy, but rather supporting you and the direction you want to take. What's most important, ultimately, is that founders and/or CEOs are in charge.


Related companies, investors and entrepreneurs

242
Bullpen Capital
Angel group/VC
Description: Bullpen Capital is second round investor who invests in companies previously seeded by the Super Angel funds.

Related news

Get-listed-300x250

Featured Stories

Splashx_health2_320x240

Other episodes of this series

Video: Mario Schlosser at Vator Splash...

18784

Fireside Chats

by Mitos Suson
Reinventing health insurance

Video: J. Craig Venter at Vator Splash...

18782

Fireside Chats

by Mitos Suson
Staying human while becoming immortal

Video: Owen Tripp at Vator Splash Health 2017

18764

Fireside Chats

by Mitos Suson
What would it be like if our doctors were perfectly matched to who we are and to our needs?

Oscar Health says government owes company...

18743

Fireside Chats

by Steven Loeb
CEO Mario Schlosser says Obamacare exchanges need "heavy fixes"

Grand Rounds CEO on lowering healthcare...

18750

Fireside Chats

by Steven Loeb
The company saves employers money by recommending more modern, cheaper and more effective treatments
Splashx_health2_320x240